应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RGNT Regentis Biomaterials Ltd.
盘前交易 09-29 08:51:59 EDT
1.89
-0.09
-4.55%
盘前
1.94
+0.05
+2.65%
07:46 EDT
最高
1.97
最低
1.86
成交量
7,510
今开
1.95
昨收
1.98
日振幅
5.81%
总市值
1,330万
流通市值
915.17万
总股本
703.65万
成交额
1.45万
换手率
0.16%
流通股本
484.22万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Ibn发布Biomedwire播客新一期节目:专访Regentis Biomaterials Ltd.首席执行官Ehud Geller博士
美股速递 · 09-18
Ibn发布Biomedwire播客新一期节目:专访Regentis Biomaterials Ltd.首席执行官Ehud Geller博士
加载更多
公司概况
公司名称:
Regentis Biomaterials Ltd.
所属市场:
AMEX
上市日期:
--
主营业务:
Regentis Biomaterials Ltd.成立于2004年,位于以色列。Regentis Biomaterials Ltd.是一家再生医学公司,致力于开发创新的组织修复解决方案,以恢复健康,提高患者的生活质量。该公司目前的努力集中在骨科治疗上,使用该公司基于可降解水凝胶植入物的Gerlin平台,以再生受损或患病组织(发炎的软骨和骨组织)。Gelrin是一种独特的水凝胶基质,由聚乙二醇二丙烯酸酯(一种参与组织工程的聚合物)和变性纤维蛋白原(一种通常在凝血中起作用的生物失活蛋白)组成。该公司的主导产品是GelrinC,一种无细胞的现成水凝胶,可固化为膝关节植入物,用于治疗关节软骨的疼痛损伤。
发行价格:
--
{"stockData":{"symbol":"RGNT","market":"US","secType":"STK","nameCN":"Regentis Biomaterials Ltd.","latestPrice":1.89,"timestamp":1790625600000,"preClose":1.98,"halted":0,"volume":7510,"hourTrading":{"tag":"盘前","latestPrice":1.94,"preClose":1.89,"latestTime":"07:46 EDT","volume":2848,"amount":5987.1558816,"timestamp":1790682402464,"change":0.05,"changeRate":0.026455,"amplitude":0.322751},"delay":0,"changeRate":-0.0454545454545455,"floatShares":4842164,"shares":7036500,"eps":-2.644,"marketStatus":"盘前交易","change":-0.09,"latestTime":"09-29 08:51:59 EDT","open":1.95,"high":1.97,"low":1.855,"amount":14463,"amplitude":0.058081,"askPrice":2.08,"askSize":100,"bidPrice":1.74,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.644,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790688600000},"marketStatusCode":1,"adr":0,"listingDate":1764824400000,"exchange":"AMEX","adjPreClose":1.89,"preHourTrading":{"tag":"盘前","latestPrice":1.94,"preClose":1.89,"latestTime":"07:46 EDT","volume":2848,"amount":5987.1558816,"timestamp":1790682402464,"change":0.05,"changeRate":0.026455,"amplitude":0.322751},"postHourTrading":{"tag":"盘后","latestPrice":1.89,"preClose":1.89,"latestTime":"18:16 EDT","volume":125,"amount":236.25,"timestamp":1790633802027,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.07035160110679733},"requestUrl":"/m/hq/s/RGNT","defaultTab":"news","newsList":[{"id":"1159809210","title":"Ibn发布Biomedwire播客新一期节目:专访Regentis Biomaterials Ltd.首席执行官Ehud Geller博士","url":"https://stock-news.laohu8.com/highlight/detail?id=1159809210","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159809210?lang=zh_cn&edition=full","pubTime":"2026-09-18 22:16","pubTimestamp":1789740970,"startTime":"0","endTime":"0","summary":"Ibn近日宣布,其旗下Biomedwire播客平台推出最新一期精彩内容。本期节目特邀嘉宾为Regentis Biomaterials Ltd.首席执行官Ehud Geller博士。\n在这期备受期待的访谈中,Geller博士将分享他在生物材料领域的独到见解,以及带领Regentis Biomaterials Ltd.在行业中开疆拓土的宝贵经验。Biomedwire播客持续致力于为听众呈现生物科技与医疗领域的前沿动态,此次对话无疑将为关注该领域的听众带来新的启发与思考。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RGNT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regentis.co.il","stockEarnings":[{"period":"1week","weight":-0.1525},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.4646},{"period":"6month","weight":-0.37},{"period":"1year","weight":-0.7638},{"period":"ytd","weight":-0.7196}],"compareEarnings":[{"period":"1week","weight":-0.0102},{"period":"1month","weight":-0.0049},{"period":"3month","weight":0.0252},{"period":"6month","weight":0.1684},{"period":"1year","weight":0.1568},{"period":"ytd","weight":0.1227}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Regentis Biomaterials Ltd.成立于2004年,位于以色列。Regentis Biomaterials Ltd.是一家再生医学公司,致力于开发创新的组织修复解决方案,以恢复健康,提高患者的生活质量。该公司目前的努力集中在骨科治疗上,使用该公司基于可降解水凝胶植入物的Gerlin平台,以再生受损或患病组织(发炎的软骨和骨组织)。Gelrin是一种独特的水凝胶基质,由聚乙二醇二丙烯酸酯(一种参与组织工程的聚合物)和变性纤维蛋白原(一种通常在凝血中起作用的生物失活蛋白)组成。该公司的主导产品是GelrinC,一种无细胞的现成水凝胶,可固化为膝关节植入物,用于治疗关节软骨的疼痛损伤。","exchange":"AMEX","name":"Regentis Biomaterials Ltd.","nameEN":"Regentis Biomaterials Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Regentis Biomaterials Ltd.(RGNT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Regentis Biomaterials Ltd.(RGNT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Regentis Biomaterials Ltd.,RGNT,Regentis Biomaterials Ltd.股票,Regentis Biomaterials Ltd.股票老虎,Regentis Biomaterials Ltd.股票老虎国际,Regentis Biomaterials Ltd.行情,Regentis Biomaterials Ltd.股票行情,Regentis Biomaterials Ltd.股价,Regentis Biomaterials Ltd.股市,Regentis Biomaterials Ltd.股票价格,Regentis Biomaterials Ltd.股票交易,Regentis Biomaterials Ltd.股票购买,Regentis Biomaterials Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Regentis Biomaterials Ltd.(RGNT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Regentis Biomaterials Ltd.(RGNT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}